Title : Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin-based therapies.

Pub. Date : 2009 Jul-Aug

PMID : 20409967






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dipeptidyl peptidase-4 (DPP-4) inhibitors prolong the half-life of endogenous GLP-1 by inhibiting its proteolytic degradation to the metabolite GLP-1(9-36), thereby increasing insulin and reducing glucagon secretion. Glucagon dipeptidyl peptidase 4 Homo sapiens
2 Dipeptidyl peptidase-4 (DPP-4) inhibitors prolong the half-life of endogenous GLP-1 by inhibiting its proteolytic degradation to the metabolite GLP-1(9-36), thereby increasing insulin and reducing glucagon secretion. Glucagon dipeptidyl peptidase 4 Homo sapiens